Using the Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) to differentiate amnestic patients with Alzheimer's disease from patients with memory deficits due to Parkinson's disease or subcortical ischemic vascular dementia.
{"title":"Using the Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) to differentiate amnestic patients with Alzheimer's disease from patients with memory deficits due to Parkinson's disease or subcortical ischemic vascular dementia.","authors":"Edoardo Barvas, Giulia Mattavelli, Susanna Guttmann, Costanza Papagno","doi":"10.1037/neu0001036","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) is a visual recognition memory measure that consists of a recognition trial to be administered after the copy and the delayed reproduction of the Modified Taylor Complex Figure Test. The aim of this study was to validate the MTCF-RT in differentiating amnestic patients with Alzheimer's disease (AD) from patients with memory deficits due to Parkinson's disease (PD) or subcortical ischemic vascular dementia (SIVD).</p><p><strong>Method: </strong>The MTCF-RT was administered to 25 amnestic patients with AD and 25 patients with memory deficits due to SIVD (<i>n</i> = 18) or PD (<i>n</i> = 7). Additionally, the recognition trial was administered to 40 neurologically unimpaired individuals. All patients were tested on a brief neuropsychological battery, and their magnetic resonance scans were assessed for medial temporal lobe atrophy.</p><p><strong>Results: </strong>MTCF-RT performance was significantly lower in the group of amnestic patients with AD than in the group of amnestic patients with non-AD disorders, whereas healthy subjects performed significantly better than the two experimental groups. The MTCF-RT allowed identifying amnestic patients with AD with 92% sensitivity and 96% specificity using a cutoff of ≤7.358, showing a higher discriminant power with respect to other long-term memory measures. Finally, MTCF-RT scores showed a high negative correlation with medial temporal lobe atrophy and a positive correlation with other long-term memory measures.</p><p><strong>Conclusions: </strong>MTCF-RT could be a useful tool, as part of a larger neuropsychological battery, for discriminating patients with AD from those with memory deficits due to PD or SIVD. (PsycInfo Database Record (c) 2025 APA, all rights reserved).</p>","PeriodicalId":19205,"journal":{"name":"Neuropsychology","volume":" ","pages":"599-609"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/neu0001036","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) is a visual recognition memory measure that consists of a recognition trial to be administered after the copy and the delayed reproduction of the Modified Taylor Complex Figure Test. The aim of this study was to validate the MTCF-RT in differentiating amnestic patients with Alzheimer's disease (AD) from patients with memory deficits due to Parkinson's disease (PD) or subcortical ischemic vascular dementia (SIVD).
Method: The MTCF-RT was administered to 25 amnestic patients with AD and 25 patients with memory deficits due to SIVD (n = 18) or PD (n = 7). Additionally, the recognition trial was administered to 40 neurologically unimpaired individuals. All patients were tested on a brief neuropsychological battery, and their magnetic resonance scans were assessed for medial temporal lobe atrophy.
Results: MTCF-RT performance was significantly lower in the group of amnestic patients with AD than in the group of amnestic patients with non-AD disorders, whereas healthy subjects performed significantly better than the two experimental groups. The MTCF-RT allowed identifying amnestic patients with AD with 92% sensitivity and 96% specificity using a cutoff of ≤7.358, showing a higher discriminant power with respect to other long-term memory measures. Finally, MTCF-RT scores showed a high negative correlation with medial temporal lobe atrophy and a positive correlation with other long-term memory measures.
Conclusions: MTCF-RT could be a useful tool, as part of a larger neuropsychological battery, for discriminating patients with AD from those with memory deficits due to PD or SIVD. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
期刊介绍:
Neuropsychology publishes original, empirical research; systematic reviews and meta-analyses; and theoretical articles on the relation between brain and human cognitive, emotional, and behavioral function.